Ізраїль - англійська - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - sitagliptin as monohydrate phosphate - film coated tablets - sitagliptin as monohydrate phosphate 25 mg - sitagliptin - sitagliptin - januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.important limitations of use:januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.januvia has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januvia.

Ізраїль - англійська - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - sitagliptin as monohydrate phosphate - film coated tablets - sitagliptin as monohydrate phosphate 50 mg - sitagliptin - sitagliptin - januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.important limitations of use:januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.januvia has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januvia.

Ізраїль - англійська - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - sitagliptin as monohydrate phosphate - film coated tablets - sitagliptin as monohydrate phosphate 100 mg - sitagliptin - sitagliptin - januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.important limitations of use:januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.januvia has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januvia.

Ізраїль - англійська - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - efavirenz - film coated tablets - efavirenz 600 mg - efavirenz - efavirenz - stocrin in combination with other antiretroviral agents, is indicated for the treatment of hiv-1-infection .

Ізраїль - англійська - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - bcg strain - powder for solution for instillation - bcg strain 200 - 800 miu - bcg vaccine - bcg vaccine - oncotice is used as a treatment of flat urothelial cell carcinoma in situ (cis) of the bladder and as an adjuvant therapy after transurethral resection (tur) of a primary or relapsing superficial papillary urothelial cell carcinoma of the bladder stage ta (grade 2 or 3) or t1 (grade 1 2 or 3). oncotice is only recommended for stage ta grade 1 papillary tumors when there is judged to be a high risk of tumor recurrence.

Європейський Союз - англійська - EMA (European Medicines Agency)

the medicines company uk ltd - bivalirudin - acute coronary syndrome - antithrombotic agents - angiox is indicated as an anticoagulant in adult patients undergoing percutaneous coronary intervention (pci), including patients with st-segment-elevation myocardial infarction (stemi) undergoing primary pci.angiox is also indicated for the treatment of adult patients with unstable angina / non-st-segment-elevation myocardial infarction (ua / nstemi) planned for urgent or early intervention.angiox should be administered with aspirin and clopidogrel.

Європейський Союз - англійська - EMA (European Medicines Agency)

eli lilly and company limited - spinosad, milbemycin oxime - antiparasitic products, insecticides and repellents, endectocides - dogs - for the treatment and prevention of flea (ctenocephalides felis) infestations in dogs where one or more of the following indications are required concurrently: prevention of heartworm disease (l3, l4 dirofilaria immitis);prevention of angiostrongylosis by reducing the level of infection with immature adult (l5) angiostrongylus vasorum;treatment of gastrointestinal nematode infections caused by hookworm (l4, immature adult, l5) and adult ancylostoma caninum), roundworms (immature adult l5, and adult toxocara canis and adult toxascaris leonina) and whipworm (adult trichuris vulpis). 

Австралія - англійська - APVMA (Australian Pesticides and Veterinary Medicines Authority)

the hunter river company pty limited - temephos; liquid hydrocarbon - topical solution/suspension - temephos organophosphorus-dithiophospha active 350.0 g/l; liquid hydrocarbon solvent other 492.0 g/l - parasiticides

Австралія - англійська - APVMA (Australian Pesticides and Veterinary Medicines Authority)

the hunter river company pty limited - cyromazine - topical solution/suspension - cyromazine triazine active 500.0 g/l - parasiticides

Австралія - англійська - APVMA (Australian Pesticides and Veterinary Medicines Authority)

the hunter river company pty limited - cyromazine - topical solution/suspension - cyromazine triazine active 60.0 g/l - parasiticides